FDA
approval
· 2019-11-06
FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
Summary
FDA approved a supplemental application for quinapril and hydrochlorothiazide fixed-dose combinations in three dosage strengths (10/12.5, 20/12.5, 20/25) from C…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 (QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5)